Benzinga | May 13, 2021 04:27PM EDT

Infinity Pharmaceuticals Q1 EPS $(0.15) Misses $(0.12) Estimate

Infinity Pharmaceuticals (NASDAQ:INFI) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.12) by 25 percent. This is a 21.05 percent increase over losses of $(0.19) per share from the same period last year.